Tecan Group AG
SIX:TECN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xinjiang Zhongtai Chemical Co Ltd
SZSE:002092
|
CN |
|
Shandong Lukang Pharmaceutical Co Ltd
SSE:600789
|
CN |
Tecan Group AG
Stock-Based Compensation
Tecan Group AG
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Tecan Group AG
SIX:TECN
|
Stock-Based Compensation
CHf3.1m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Stock-Based Compensation
CHf3.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Stock-Based Compensation
CHf7.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Stock-Based Compensation
CHf57m
|
CAGR 3-Years
21%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Stock-Based Compensation
€2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tecan Group AG
Glance View
Nestled in the heart of Switzerland lies Tecan Group AG, a company that has been quietly revolutionizing the laboratory world. Founded in 1980, Tecan has transformed itself from a small enterprise into a powerhouse in the life sciences and diagnostics sectors. The company's journey is one of precision and innovation, as it specializes in the development, production, and distribution of sophisticated laboratory instruments and solutions. These solutions are not merely products; they are the linchpins of automation that help streamline research, diagnostics, and the pharmaceutical sectors. Tecan's knack for integrating complex biochemical processes into accessible technology has proven critical for laboratories seeking speed and accuracy in processes like sample handling, testing, and data management. Tecan's business model thrives on a multifaceted approach. It sells its high-tech instruments and consumables directly to a diverse client base, including pharmaceutical companies, biotechnology firms, and research institutions. Beyond selling physical products, Tecan also benefits from providing value-added services such as after-sales support and bespoke system adaptations, ensuring that its clients can optimize their workflows. By combining cutting-edge technology with customer-centric service offerings, Tecan ensures recurring revenue streams. Its strategic prowess in securing long-term partnerships with leading institutions further cements its stance as not just a vendor, but a reliable partner in scientific discovery and healthcare advancement.
See Also
What is Tecan Group AG's Stock-Based Compensation?
Stock-Based Compensation
3.1m
CHF
Based on the financial report for Dec 31, 2025, Tecan Group AG's Stock-Based Compensation amounts to 3.1m CHF.
What is Tecan Group AG's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-27%
Over the last year, the Stock-Based Compensation growth was -25%. The average annual Stock-Based Compensation growth rates for Tecan Group AG have been -39% over the past three years , -27% over the past five years .